FLASH2 Study opens patient enrollment Princeton, NJ – December 16, 2024 – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical […]
Significant Efficacy against Plaque Lesions Also Demonstrated with HyBryte™ PRINCETON, N.J., Dec. 2, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare […]
Interview with Christopher Schaber, PhD CEO and President […]
CAMBRIDGE, MA / ACCESSWIRE / November 19, 2024 / Peer To Peer Network, Inc. (OTC:PTOP) is excited to announce a strategic partnership with Pantheon Technologies Inc., an emerging leader in AI technology, which will further elevate PTOP’s […]
IRVINE, CA / ACCESSWIRE / October 31, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2025 first quarter ended September 30, 2024. The Company also filed its Quarterly Report on Form 10-Q […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com